Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66048 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL1963633 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782982 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL338159 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9271352 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782992 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782989 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782996 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782987 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL911207 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118947817-A | Application of xylo-oligosaccharide in regulating rumen flora and metabolites of ruminants | 宁夏大学 | 2024-11-15 | — | — | CN | claimed |
| CN-116355244-A | Photo-cured cellulose-reinforced degradable polyester elastomer and preparation method thereof | 浙江大学台州研究院 | 2023-06-30 | — | — | CN | claimed |
| CN-116355245-A | Photo-cured bacterial cellulose reinforced degradable polyester elastomer and preparation method thereof | 浙江大学台州研究院 | 2023-06-30 | — | — | CN | claimed |
| CN-113341043-B | Method for deducing early death and post-death inundation time of corpse in water based on metabonomics marker and application thereof | 中国医科大学 | 2022-11-25 | — | — | CN | claimed |
| EP-3377487-B1 | COMPOUNDS FOR MEDICINAL APPLICATIONS | AusVir Therapeutics Pty Ltd (AU) | 2022-01-12 | — | — | EP | claimed |
| CN-113341043-A | Method for deducing early death and post-death inundation time of corpse in water based on metabonomics marker and application thereof | 中国医科大学 | 2021-09-03 | — | — | CN | claimed |
| US-11007274-B2 | Compounds for medicinal applications | AusVir Therapeutics Pty Ltd (AU) | 2021-05-18 | — | — | US | claimed |
| EP-3377487-A1 | COMPOUNDS FOR MEDICINAL APPLICATIONS | Australian Biomedical Co. Pty Ltd (AU) | 2018-09-26 | — | — | EP | claimed |
| US-20180264128-A1 | COMPOUNDS FOR MEDICINAL APPLICATIONS | Australian Biomedical Co. Pty Ltd. (AU) | 2018-09-20 | — | — | US | claimed |
| US-8323678-B2 | Implantable medical devices comprising poly[l-lactide-co-(3,6-dialkyl-1,4-dioxane-2,5-dione)] | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-12-04 | — | — | US | claimed |
| US-20110270387-A1 | Implantable Medical Devices Comprising Poly[L-Lactide-Co-(3,6-Dialkyl-1,4-Dioxane-2,5-Dione)] | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-11-03 | — | — | US | claimed |
| EP-1792894-B1 | Contrast agents | GE HEALTHCARE AS (NO) | 2010-09-22 | — | — | EP | claimed |
| US-7485753-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2009-02-03 | — | — | US | claimed |
| US-20080199402-A1 | Contrast Agents | GE HEALTHCARE AS (NO) | 2008-08-21 | — | — | US | claimed |
| EP-1792894-A2 | Contrast agents | GE Healthcare AS (NO) | 2007-06-06 | — | — | EP | claimed |
| US-20070007489-A1 | Heat transfer medium composition | SHISHIAI-KABUSHIKIGAISHA (JP) | 2007-01-11 | — | — | US | claimed |
| EP-1698678-A1 | HEAT CARRIER COMPOSITION | Shishiai-Kabushikigaisha (JP) | 2006-09-06 | — | — | EP | claimed |
| JP-8311027-A | — | — | None | — | — | JP | disclosed |
| US-4132702-A | Phenol esters and amides and polymers stabilized therewith | CIBA-GEIGY CORPORATION (US) | 1979-01-02 | — | — | US | disclosed |
| US-3969294-A | Segmented copolyester adhesives stabilized by alkaline earth oxides and carboxylic compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11007274-B2 | Compounds for medicinal applications | HAVCR2, ENGASE, DNPEP | POLB 2756/4885TDP1 2545/4885CTDSP1 41/4885 |
| US-20080199402-A1 | Contrast Agents | PYM1, MIA3, IPO11 | POLB 3523/4885TDP1 2302/4885CTDSP1 2878/4885 |
| US-20180264128-A1 | COMPOUNDS FOR MEDICINAL APPLICATIONS | HAVCR2, ENGASE, DNPEP | POLB 2756/4885TDP1 2545/4885CTDSP1 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.